Xcout IntelMagicRNA competitors & alternatives
The 12 closest competitors and alternatives to MagicRNA among drug discovery companies — ranked by similarity to what MagicRNA actually does, not by market-cap band.
Subscribe to see MagicRNA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About MagicRNA
Founded in 2021 and headquartered in Shenzhen, China, MagicRNA Biotechnology Co., Ltd. is a clinical-stage biotechnology company focused on nucleic acid drug delivery and the research and development of next-generation mRNA and lipid nanoparticle technologies for the treatment of cancer and infectious diseases.
MagicRNA at a glance
MagicRNA is a drug discovery company headquartered in China. Xcout tracks 1 named person at MagicRNA, including Zha Gaofeng (founder of MagicRNA).
MagicRNA leadership
- Zha Gaofengfounder of MagicRNA
Top 12 MagicRNA competitors
Ranked by semantic similarity — how close each company is to MagicRNA by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Similar drug discovery company
Smartbax is a biotechnology startup founded in Munich, Germany, in 2021, dedicated to developing innovative next-generation antibiotics to combat the rising threat of multidrug-resistant bacteria.
Similar drug discovery company
Ona Therapeutics is a biotechnology company founded in 2019 and headquartered in Barcelona, Spain, specializing in the design of first-in-class biotherapeutics and ADCs to attack advanced cancer.
Similar drug discovery company
Mabsoft Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative therapeutic solutions, including antibody-drug conjugates and immuno-stimulating antibody conjugates for solid tumors and infectious diseases. The company's pipeline features proprietary candidates such as the antibody-drug conjugate MST-168.
Similar drug discovery company
LyncBio Therapeutics is an innovative drug discovery and development company headquartered in Shanghai, China, with research facilities in Suzhou. The firm specializes in the advancement of antibody-drug conjugate (ADC) therapeutics.
Similar drug discovery company
Versameb AG is a privately held biopharmaceutical company focused on discovering and developing innovative RNA-based therapeutics.
Similar drug discovery company
Kupando is a pioneering Berlin-based biopharmaceutical and biotech company headquartered in Schönefeld, Germany. The company is focused on the research and clinical development of innovative treatments to fight cancer and infectious diseases.
Similar drug discovery company
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
Similar drug discovery company
Mighty Therapeutics, formerly known as Stealth BioTherapeutics, focuses on mitochondrial medicine. The company targets mitochondrial dysfunction associated with rare genetic mitochondrial diseases and common diseases of aging through targeted scientific research and treatment development.
Similar drug discovery company
iRegene Therapeutics is a biotechnology company headquartered in Wuhan, China, with additional facilities in Suzhou. The firm specializes in regenerative medicine and advanced cell therapies designed to redefine modern medicine.
Similar drug discovery company
Renasis Bio Ltd. is a stealth-mode private company headquartered in Rehovot, Israel, established in 2025. The firm is developing an AI-driven drug discovery platform focused on RNA-targeting small molecules to advance RNA druggability.
Similar drug discovery company
Momotaro-Gene Inc. is a drug discovery company established in 2007 and headquartered in Okayama, Japan. The company focuses on pharmaceutical research and the development of next-generation cancer therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of MagicRNA and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for MagicRNAand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →